175 related articles for article (PubMed ID: 35028616)
1. Deletions in
Jiang SH; Mercan S; Papa I; Moldovan M; Walters GD; Koina M; Fadia M; Stanley M; Lea-Henry T; Cook A; Ellyard J; McMorran B; Sundaram M; Thomson R; Canete PF; Hoy W; Hutton H; Srivastava M; McKeon K; de la Rúa Figueroa I; Cervera R; Faria R; D'Alfonso S; Gatto M; Athanasopoulos V; Field M; Mathews J; Cho E; Andrews TD; Kitching AR; Cook MC; Riquelme MA; Bahlo M; Vinuesa CG
Cell Rep Med; 2021 Dec; 2(12):100475. PubMed ID: 35028616
[TBL] [Abstract][Full Text] [Related]
2. Lupus nephritis and beyond: Kidney-intrinsic genetic risk for antibody deposition.
Chernova I; Craft J
Cell Rep Med; 2021 Dec; 2(12):100479. PubMed ID: 35028618
[TBL] [Abstract][Full Text] [Related]
3. Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF.
Jacob CO; Pricop L; Putterman C; Koss MN; Liu Y; Kollaros M; Bixler SA; Ambrose CM; Scott ML; Stohl W
J Immunol; 2006 Aug; 177(4):2671-80. PubMed ID: 16888029
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 binding protein links circulating microparticles with electron dense glomerular deposits in lupus nephritis.
Nielsen CT; Østergaard O; Rekvig OP; Sturfelt G; Jacobsen S; Heegaard NH
Lupus; 2015 Oct; 24(11):1150-60. PubMed ID: 25837289
[TBL] [Abstract][Full Text] [Related]
5. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice.
Pawar RD; Pitashny M; Gindea S; Tieng AT; Levine B; Goilav B; Campbell SR; Xia Y; Qing X; Thomas DB; Herlitz L; Berger T; Mak TW; Putterman C
Arthritis Rheum; 2012 May; 64(5):1620-31. PubMed ID: 22083497
[TBL] [Abstract][Full Text] [Related]
7. Annexin II-binding immunoglobulins in patients with lupus nephritis and their correlation with disease manifestations.
Cheung KF; Yung S; Chau MK; Yap DY; Chan KW; Lee CK; Tang CS; Chan TM
Clin Sci (Lond); 2017 Apr; 131(8):653-671. PubMed ID: 28183811
[TBL] [Abstract][Full Text] [Related]
8. Urinary loss of immunoglobulin G anti-F(ab)2 and anti-DNA antibody in systemic lupus erythematosus nephritis.
Williams RC; Malone CC; Miller RT; Silvestris F
J Lab Clin Med; 1998 Sep; 132(3):210-22. PubMed ID: 9735927
[TBL] [Abstract][Full Text] [Related]
9. Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies.
Kenderov A; Minkova V; Mihailova D; Giltiay N; Kyurkchiev S; Kehayov I; Kazatchkine M; Kaveri S; Pashov A
Clin Exp Immunol; 2002 Jul; 129(1):169-76. PubMed ID: 12100037
[TBL] [Abstract][Full Text] [Related]
10. Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis.
Zykova SN; Tveita AA; Rekvig OP
PLoS One; 2010 Aug; 5(8):. PubMed ID: 20856893
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Utility of Galactose-Deficient Immunoglobulin A1 Immunostaining in the Differentiation of Lupus Nephritis and Immunoglobulin A Nephropathy.
Bu L; Ye B; Kouri AM; Kim Y
Glomerular Dis; 2021 Apr; 1(1):34-39. PubMed ID: 36751490
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of endogenous Vangl2/Vangl1 heteromeric protein complexes.
Belotti E; Puvirajesinghe TM; Audebert S; Baudelet E; Camoin L; Pierres M; Lasvaux L; Ferracci G; Montcouquiol M; Borg JP
PLoS One; 2012; 7(9):e46213. PubMed ID: 23029439
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
14. Nrf2-deficient female mice develop lupus-like autoimmune nephritis.
Yoh K; Itoh K; Enomoto A; Hirayama A; Yamaguchi N; Kobayashi M; Morito N; Koyama A; Yamamoto M; Takahashi S
Kidney Int; 2001 Oct; 60(4):1343-53. PubMed ID: 11576348
[TBL] [Abstract][Full Text] [Related]
15. The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.
Koh AE; Njoroge SW; Feliu M; Cook A; Selig MK; Latchman YE; Sharpe AH; Colvin RB; Paul E
J Autoimmun; 2011 Aug; 37(1):48-57. PubMed ID: 21561736
[TBL] [Abstract][Full Text] [Related]
16. Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid.
Yung S; Zhang Q; Zhang CZ; Chan KW; Lui SL; Chan TM
Arthritis Rheum; 2009 Jul; 60(7):2071-82. PubMed ID: 19565476
[TBL] [Abstract][Full Text] [Related]
17. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
Cagnoli L;
G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
[TBL] [Abstract][Full Text] [Related]
18. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis.
van Bruggen MC; Kramers C; Walgreen B; Elema JD; Kallenberg CG; van den Born J; Smeenk RJ; Assmann KJ; Muller S; Monestier M; Berden JH
Nephrol Dial Transplant; 1997 Jan; 12(1):57-66. PubMed ID: 9027774
[TBL] [Abstract][Full Text] [Related]
19. Lupus nephritis progression in FcγRIIB-/-yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease.
Horvei KD; Pedersen HL; Fismen S; Thiyagarajan D; Schneider A; Rekvig OP; Winkler TH; Seredkina N
PLoS One; 2017; 12(11):e0188863. PubMed ID: 29190833
[TBL] [Abstract][Full Text] [Related]
20. Fingerprint and other organised deposits in lupus nephritis.
Hvala A; Kobenter T; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):711-5. PubMed ID: 11020962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
